Previous studies showed that lost of cyclin G2 expression was associated with the development of gastric, ovarian, and breast cancers [42]–[44], but activation of Wnt/β-catenin signaling [38], [45], [46] indicated a potential link between them. This evidence concerns the gene CCNG2 and breast carcinoma.